News

STAT9h

FDA permits use of Sarepta Therapeutics’ Duchenne therapy in younger patients after short-lived halt

The FDA said it was clearing the way for Sarepta Therapeutics to resume shipments of its gene therapy for Duchenne muscular ...

FDA partially lifts hold on Sarepta's Duchenne gene therapy after community outcry

The FDA has partially reversed course on its push to halt shipments of a controversial gene therapy made by Sarepta ...